Monday - Friday
8:30AM to 5:30PM CET

Can't find your specific product? Send us an enquiry in our form!

CPHI Frankfurt 2025 – Book your meeting now!

We are delighted to announce our participation in CPHI Frankfurt 2025. This is a fantastic opportunity to connect, collaborate, and explore new possibilities together.

If you would like to schedule a meeting with us, please do so now by filling out the form at the bottom of this page. We look forward to seeing you there!

Modified Phosphoramidites

We are thrilled to announce that Summit Pharmaceuticals Europe is now promoting new modified nucleic acids (phosphoramidites) from Luxna Biotech Co., Ltd.(“Luxna”), a leading biotech company in Japan specializing in the research and development of oligonucleotide therapeutics.

DAIB (Diacetoxyiodo)benzene (CAS 3240-34-4) / DAIM (Diacetoxyiodo)mesitylene (CAS 33035-41-5)

Low-toxic versatile oxidizing agents based on hypervalent iodine.
DAIM is particularly suited for use with low-polar solvents.

D-Epoxone (CAS 18422-53-2)

Asymmetric epoxidation catalyst for the production of chiral epoxides. High-purity, heavy metal-free. Eco-friendly production process.

Buchwald Phosphine Ligands

Highly-effective ligands for Pd-catalyzed cross-coupling reactions.

Thank you for joining this CPhI 2025 in Frankfurt!

November 17, 2025

What an incredible and productive experience at CPHI Frankfurt this year! ✨
We had the chance to connect, share insights, and explore innovative solutions shaping the pharmaceutical industry. 🤝
We’re already looking forward to continuing this journey at CPHI Milan 2026—see you there! 🚀

Other news

No post found!